Biblio

Export 170 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
A. Koppara, Wolfsgruber, S., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H., Heuser, I., Peters, O., Reischies, F. M., Jahn, H., Luckhaus, C., Hüll, M., Gertz, H. - J., Schröder, J., Pantel, J., Rienhoff, O., Rüther, E., Henn, F., Wiltfang, J., Maier, W., Jessen, F., Kornhuber, J., and Wagner, M., “The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 547-60, 2016.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S., “Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
S. Konwar, Manca, R., De Marco, M., Soininen, H., and Venneri, A., “Interactive effects of ɛ4 status and vascular burden on white matter microstructural integrity in aging with and without neurocognitive decline.”, J Alzheimers Dis, p. 13872877251320660, 2025.
D. Kontaxopoulou, Beratis, I. N., Fragkiadaki, S., Pavlou, D., Andronas, N., Yannis, G., Economou, A., Papanicolaou, A. C., and Papageorgiou, S. G., “Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 2, pp. 617-627, 2018.
K. Konishi, Joober, R., Poirier, J., MacDonald, K., Chakravarty, M., Patel, R., Breitner, J., and Bohbot, V. D., “Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1493-1507, 2018.
T. Kondo, Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S. - I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W. L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., and Inoue, H., “Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.”, Cell Stem Cell, vol. 12, no. 4, pp. 487-96, 2013.
M. Kolarova, Sengupta, U., Bartos, A., Ricny, J., and Kayed, R., “Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls.”, J Alzheimers Dis, vol. 58, no. 2, pp. 471-478, 2017.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., “Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
A. M. Koivisto, Kurki, M. I., Alafuzoff, I., Sutela, A., Rummukainen, J., Savolainen, S., Vanninen, R., Jääskeläinen, J. E., Soininen, H., and Leinonen, V., “High Risk of Dementia in Ventricular Enlargement with Normal Pressure Hydrocephalus Related Symptoms1.”, J Alzheimers Dis, vol. 52, no. 2, pp. 497-507, 2016.
I. V. Kohler, Kämpfen, F., Bandawe, C., and Kohler, H. - P., “Cognition and Cognitive Changes in a Low-Income Sub-Saharan African Aging Population.”, J Alzheimers Dis, vol. 95, no. 1, pp. 195-212, 2023.
A. Tom Kodamullil, Iyappan, A., Karki, R., Madan, S., Younesi, E., and Hofmann-Apitius, M., “Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1045-1055, 2017.
G. Koch, Di Lorenzo, F., Del Olmo, M. Fernandez, Bonní, S., Ponzo, V., Caltagirone, C., Bozzali, M., and Martorana, A., “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
A. Kobro-Flatmoen, Hormann, T. Meier, and Gouras, G., “Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 2, pp. 719-733, 2023.
M. Kobayashi, Yamada, Y., Shinkawa, K., Nemoto, M., Nemoto, K., and Arai, T., “Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1075-1089, 2022.
S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., “Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.”, J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
M. Kleinschmidt, Schoenfeld, R., Göttlich, C., Bittner, D., Metzner, J. Erich, Leplow, B., and Demuth, H. - U., “Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.”, J Alzheimers Dis, vol. 50, no. 1, pp. 111-26, 2016.
H. - W. Klafki, Hafermann, H., Bauer, C., Haussmann, U., Kraus, I., Schuchhardt, J., Muck, S., Scherbaum, N., and Wiltfang, J., “Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 691-705, 2016.
Y. Kitamura, Inden, M., Kimoto, Y., Takata, K., Yanagisawa, D., Hijioka, M., Ashihara, E., Tooyama, I., Shimohama, S., and Ariga, H., “Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 67-72, 2017.
N. Kitaguchi, Tatebe, H., Sakai, K., Kawaguchi, K., Matsunaga, S., Kitajima, T., Tomizawa, H., Kato, M., Sugiyama, S., Suzuki, N., Mizuno, M., Takechi, H., Nakai, S., Hiki, Y., Kushimoto, H., Hasegawa, M., Yuzawa, Y., and Tokuda, T., “Influx of Tau and Amyloid-β Proteins into the Blood During Hemodialysis as a Therapeutic Extracorporeal Blood Amyloid-β Removal System for Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 687-707, 2019.
K. Kitagawa, Toi, S., Hosoya, M., Seki, M., Yamagishi, S., Hoshino, T., and Yoshizawa, H., “Small Vessel Disease Burden Predicts Incident Dementia and Poor Functional Outcome in Independent Outpatients.”, J Alzheimers Dis, vol. 101, no. 3, pp. 751-760, 2024.
T. Kishi, Matsuda, Y., and Iwata, N., “Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.”, J Alzheimers Dis, vol. 64, no. 1, pp. 43-48, 2018.
T. Kishi, Matsunaga, S., and Iwata, N., “A Meta-Analysis of Memantine for Depression.”, J Alzheimers Dis, vol. 57, no. 1, pp. 113-121, 2017.
T. Kishi, Matsunaga, S., Oya, K., Nomura, I., Ikuta, T., and Iwata, N., “Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.”, J Alzheimers Dis, vol. 60, no. 2, pp. 401-425, 2017.
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., “Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
B. - E. Kirsebom, Espenes, R., Waterloo, K., Hessen, E., Johnsen, S. Harald, Bråthen, G., Aarsland, D., and Fladby, T., “Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1621-1631, 2017.

Pages